The identification of carbapenemase-producing Enterobacteriaceae in environmental samples from New Delhi, India, in 2011 had important clinical implications for people living in low-resource settings who are dependent on public water and sanitation facilities.
1 To ensure early detection and international surveillance of resistance, it was advised to incorporate environmental sampling as well as examination of clinical isolates in screening strategies.
1,2 Currently, carbapenem-resistant strains, including
Pseudomonas aeruginosa and
Acinetobacter baumannii, are also spreading rapidly to and within high-resource countries.
3,4 Therefore, the World Health Organization (WHO) has issued measures to control the spread of carbapenemase-producing microorganisms, focusing on Enterobacteriaceae,
P aeruginosa, and
A baumannii.
5 One of the strategies to halt the spread of multidrug-resistant microorganisms is through implementing the WHO infection prevention and control core components, of which the hospital-built environment is added as one of the new core elements.
6 Sinks are part of this hospital-built environment; the removal of sinks from rooms in the intensive care unit has resulted in the reduction of colonization and infections with multidrug-resistant microorganisms.
7-9 In addition, waste water has been recently identified as a source of transmission of carbapenemase-producing Enterobacteriaceae in an intensive care unit in the United States.
10 Furthermore, hospital plumbing systems have been revealed as a reservoir of carbapenem resistance by genomic analysis,
11 and shower faucets have been shown to be important in the level of air contamination in an experimental shower unit.
12 We report the results of a risk assessment conducted after the identification of an unexpected, severe, and lethal hospital-acquired infection caused by carbapenemase-producing
P aeruginosa in a carbapenemase-low endemic setting.